Ecopipam Hydrochloride not checked

Emalex Biosciences Inc. · PSYRX101 · SCH 39166

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
15 in total · 2 in the EU

What this is

How it works
How it works isn't classified yet
Tested for
Tourette Syndrome
Main trialPhase 3
“The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tourette's Syndrome (TS).”In the company’s words, NCT06021522 on ClinicalTrials.gov
Other names
Ecopipam · PSYRX101 · SCH 39166 · ecopipam HCL

Other drugs for Tourette Syndrome

All 3 drugs for Tourette Syndrome

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials15

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Feb 2028 A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Phase 3Terminated Dec 2013 Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Phase 3Completed 13 Jan 2025 Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Phase 2Completed May 2012 Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Phase 2Completed Dec 2019 Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Phase 2Completed 23 Sep 2021 Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
Phase 2Completed 7 Mar 2022 Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Phase 2Completed 11 Nov 2022 Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
Phase 1Terminated 2 Apr 2021 Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Phase 1Completed 6 Jul 2021 Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
Phase 1Completed 7 Sep 2021 Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects
Phase 1Completed 1 Aug 2022 Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
Phase 1Completed 7 May 2023 Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
Phase 1Completed 14 May 2024 Drug Interaction Study
Phase 1Completed 22 Dec 2024 Food-effect Study of Ecopipam Pharmacokinetics
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Ecopipam Hydrochloride

Following is part of Solo: you see every change to Ecopipam Hydrochloride the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in